35Pharma is a Biotech company. It has raised $53M in total funding. Latest round: Series C.
35Pharma is a Biotech company. 35Pharma has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in December 2024. The round record for 35Pharma runs through 2024; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Vivo Capital, Janus Henderson Investors, Deep Track Capital, Paradigm BioCapital Advisors, Columbia Threadneedle and 4 others. 10 distinct backers are named across the disclosed rounds.
Every 35Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026